1. Introduction {#sec1-nutrients-11-01375}
===============

The gut is critical to host health and disease development through interactions with microbes that colonize the gut and establishment of the gut epithelial barrier \[[@B1-nutrients-11-01375],[@B2-nutrients-11-01375]\]. Major gut functions include absorption of water and nutrients; secretion of digestive enzymes, bile, and mucus; and motility of luminal contents down the gastrointestinal tract and in a mixing motion to ensure adequate contact with the epithelium for absorption \[[@B3-nutrients-11-01375]\]. In health, the gut is involved in vitamin synthesis \[[@B4-nutrients-11-01375]\], nutrient metabolism \[[@B5-nutrients-11-01375]\], and protection against pathogens \[[@B1-nutrients-11-01375],[@B6-nutrients-11-01375]\]. It is also important for brain function: a direct and bidirectional channel of communication exists between the gut and the brain, dubbed the gut-brain axis, which includes a connection between the enteric and central nervous systems (CNS) \[[@B7-nutrients-11-01375]\]. Microbes that reside in the gut, their metabolites \[[@B8-nutrients-11-01375]\], hormones \[[@B9-nutrients-11-01375]\], and immune factors \[[@B10-nutrients-11-01375]\], have been shown to affect gut and brain function through this axis in humans and animals \[[@B7-nutrients-11-01375]\]. Since microbes and the metabolites they produce can activate host immune, metabolic, and stress pathways once they leave the gut environment \[[@B11-nutrients-11-01375]\], an important part of the gut-microbe-host relationship is the separation between the gut tissue, the gut ecosystem, and the rest of the host.

This separation is mediated by the intestinal epithelial barrier, which lies at the interface between exogenous host factors and the internal gut microenvironment and helps to regulate microbe-host interactions. During periods of optimal nutrition and host health, two key cell types are involved in supporting and maintaining this gut barrier: Paneth cells and enteric glial cells (EGCs). Paneth cells reside in the epithelium of the small intestine (SI), maintain gut integrity and prevent microbial translocation through production of tight junction (TJ) proteins \[[@B12-nutrients-11-01375]\], and produce antimicrobial peptides (AMPs) which regulate the host-microbe relationship \[[@B13-nutrients-11-01375]\]. As well, due to their proximity to crypt stem cells \[[@B14-nutrients-11-01375],[@B15-nutrients-11-01375]\], Paneth cells can affect gut epithelial cell differentiation and gut maturation \[[@B14-nutrients-11-01375],[@B15-nutrients-11-01375]\]. Toll-like receptors (TLRs), which activate the innate immune response when bacterial components are recognized in the gut environment, are purported to play a key role in inducing Paneth AMP production \[[@B16-nutrients-11-01375]\]. In addition, EGCs are part of the enteric nervous system (ENS) and gut-brain axis \[[@B17-nutrients-11-01375]\], and respond to and control gut inflammation \[[@B18-nutrients-11-01375],[@B19-nutrients-11-01375]\]. EGCs also influence gut integrity and permeability \[[@B20-nutrients-11-01375]\] through their long cytoplasmic processes which make direct contact with the barrier \[[@B21-nutrients-11-01375]\]. Other enteric cells, such as goblet cells, maintain gut barrier integrity through their production of mucus \[[@B12-nutrients-11-01375]\]. Importantly, Paneth cells and EGCs are established in early development ([Figure S1](#app1-nutrients-11-01375){ref-type="app"}) \[[@B14-nutrients-11-01375],[@B22-nutrients-11-01375]\], suggesting they are key for early and lifelong gut and brain health.

The integrity of the gut barrier and the composition and function of the gut microbiome can be greatly affected by the diet of the host \[[@B23-nutrients-11-01375],[@B24-nutrients-11-01375],[@B25-nutrients-11-01375]\], since the indigestible polysaccharides in the host diet become gut bacterial substrates and nutrients \[[@B26-nutrients-11-01375]\]. Indeed, adaptations to gut bacterial metabolism and transcription occur within days of dietary changes in humans \[[@B24-nutrients-11-01375]\]. In response to both over- \[[@B27-nutrients-11-01375]\] and undernutrition \[[@B28-nutrients-11-01375]\], collectively known as malnutrition, gut barrier function and integrity can become dysregulated, leading to gut microbial dysbiosis, altered gut function, and a leaky gut barrier. Yet, few studies have elucidated the effects of malnutrition on Paneth cell \[[@B29-nutrients-11-01375],[@B30-nutrients-11-01375],[@B31-nutrients-11-01375],[@B32-nutrients-11-01375],[@B33-nutrients-11-01375]\] and EGC \[[@B34-nutrients-11-01375],[@B35-nutrients-11-01375]\] development and function (indeed, none have examined EGCs during undernutrition to our knowledge), or how either of these cells are affected by and/or perpetuate gut dysfunction. Since the rates of both undernutrition and underweight \[[@B36-nutrients-11-01375]\], as well as over-nutrition and obesity \[[@B36-nutrients-11-01375]\], are increasing worldwide, and a compromised gut barrier is both caused by, and leads to, a variety of immune-related, and chronic diseases, the effects of malnutrition on the gut-host relationship are important to understand.

During pregnancy, the intestinal epithelial barrier and the microbes contained within the gut are doubly important, as they protect both the mother and, by association, the fetus from harmful bacteria and xenobiotics \[[@B1-nutrients-11-01375],[@B37-nutrients-11-01375]\], produce nutrients required for pregnancy health \[[@B38-nutrients-11-01375]\], and absorb nutrients into the blood stream that are vital to fetal development \[[@B39-nutrients-11-01375],[@B40-nutrients-11-01375]\]. We and others have shown that maternal malnutrition impacts the maternal gut microbiome \[[@B41-nutrients-11-01375],[@B42-nutrients-11-01375],[@B43-nutrients-11-01375],[@B44-nutrients-11-01375]\] and is associated with increased levels inflammation in the maternal gut and peripheral circulation \[[@B41-nutrients-11-01375],[@B44-nutrients-11-01375]\]. In offspring, a mature intestinal epithelial barrier ensures a healthy and homeostatic gut environment \[[@B45-nutrients-11-01375]\], which allows the offspring to appropriately respond to infections \[[@B45-nutrients-11-01375]\], absorb and produce nutrients \[[@B16-nutrients-11-01375]\], and likely establish optimal communication with the brain and other organs \[[@B7-nutrients-11-01375]\]. Still, little is known about how malnutrition impacts the maternal epithelial barrier during pregnancy, a 'stress-test' in itself, or whether maternal malnutrition adversely programmes fetal gut development and function. Additionally, although we know that Paneth cells \[[@B14-nutrients-11-01375]\] and EGCs \[[@B46-nutrients-11-01375],[@B47-nutrients-11-01375]\] are laid down and functional in early life, we know less about how early life adversity, including poor nutrition, or gut microbes, may influence their development and function.

We therefore sought to answer two questions: how does malnutrition during pregnancy affect maternal gut barrier function, and does maternal malnutrition impact fetal gut integrity, function, and development? We focused on Paneth cells and EGCs to answer these questions as these cells may be critical for long-term gut function and communication with the brain. We hypothesized that malnutrition would lead to an adverse maternal gut environment, and that mothers fed a high fat (HF) diet and their offspring would display the most affected gut function, since our previous work has demonstrated that the maternal gut is especially affected by a HF diet \[[@B41-nutrients-11-01375]\]. We also hypothesized that, due to the changes in maternal diets and gut environments, the fetal gut would display aberrant gut integrity and function and EGC development, with different outcomes in fetuses from undernourished (UN) and HF mothers.

2. Materials and Methods {#sec2-nutrients-11-01375}
========================

2.1. Animal Model {#sec2dot1-nutrients-11-01375}
-----------------

All housing and breeding procedures were approved by the Animal Care Committee at Mount Sinai Hospital (Toronto, ON, Canada; AUP 16-0091H). Male and female C57BL/6J mice (Jackson Laboratories, Bar Harbor, ME, USA) were housed using a 12:12 light:dark cycle at 25 °C, with free access to food and water. Females were randomized into three diet groups: mice fed control diet ad libitum before and throughout pregnancy (CON, *n* = 7); mice fed control diet ad libitum before mating and undernourished by 30% from gestational day (d) 5.5 to 17.5 (UN, *n* = 7); and mice fed high fat diet (60% of calories as fat) ad libitum from 8 weeks prior to mating and through pregnancy (HF, *n* = 8). Males were fed control diet ad libitum and mated with females at \~10 weeks of age. Females were housed individually following confirmation of pregnancy status (presence of vaginal sperm plug). Dams were weighed weekly before and daily during pregnancy.

2.2. Maternal SI and Fetal Gut Collection {#sec2dot2-nutrients-11-01375}
-----------------------------------------

Dams were sacrificed by cervical dislocation at d18.5 (term = d19). Fetuses were collected, weighed, and at random, one male and female fetus from each litter was used for fetal biospecimen collections. Maternal and fetal gastrointestinal (GI) tracts were dissected as detailed previously \[[@B41-nutrients-11-01375]\]. A 2--5 mm piece of maternal SI from the mid portion of the SI (representing the jejunum) and the entire fetal gut were flash frozen in liquid nitrogen then stored at −80 °C for later molecular analyses. Another 2--5 mm of maternal SI from the mid portion was flushed with buffered 4% paraformaldehyde (PFA), cut longitudinally, and cut into two pieces for fixing in 4% PFA at 4 °C overnight. Fixed SI were washed thrice with 1× PBS and stored in 70% ethanol until paraffin embedded for later immunohistochemical analyses.

2.3. RNA Extraction and mRNA Expression Analysis {#sec2dot3-nutrients-11-01375}
------------------------------------------------

Total RNA was extracted from maternal SI and fetal guts using the Tissue Lyser II (Qiagen, Hilden, NRW, Germany) and RNA extraction kits following manufacturer's instructions (QIAGEN RNeasy Plus Mini Kit, Toronto, ON, Canada). Eluted RNA quality and quantity were assessed by spectrophotometry (DeNovix, Wilmington, DE, USA), and 1 μg of RNA was reverse transcribed using 5× iScript Reverse Transcription Supermix (Bio-Rad, Mississauga, ON, Canada).

We focused on genes involved in gut barrier function, integrity, and development to establish how maternal malnutrition may impact the maternal gut and, by consequence, fetal gut and ENS development ([Table 1](#nutrients-11-01375-t001){ref-type="table"}). mRNA expression data were normalized to the geometric mean of the three stably-expressed reference genes: TATA-Box Binding Protein (*Tbp*), Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Zeta (*Ywhaz*), and Beta-actin (*Actb*). Primers were designed from gene sequences found in the NCBI Nucleotide Database or taken from the literature and analyzed using NCBI Primer-BLAST and Oligo Calc (Northwestern University, Evanston, IL, USA) for appropriate gene targeting and properties. Amplification and detection of mRNA expression was measured using CFX384 Touch Real-Time PCR Detection System (Bio-Rad). Samples, standards, and controls were pipetted in triplicate. Inter-run calibrators and non-template controls were run alongside each gene to normalize between plates and to assess contamination, respectively. The PCR cycling conditions were: 30 s at 95 °C, 40 × 5 s at 95 °C, 20 s at 60 °C. Data were analyzed applying the Pfaffl method \[[@B48-nutrients-11-01375]\].

2.4. Expression and Localization of Lysozyme Protein and Quantification of Goblet Cells in Maternal SI {#sec2dot4-nutrients-11-01375}
------------------------------------------------------------------------------------------------------

Immunohistochemistry (IHC) was used to localize and semi-quantify immunoreactive (ir) staining of lysozyme (Lyz) and to quantify goblet cell number. Five millimeter sections of maternal SI were cut from paraffin-embedded blocks and mounted onto glass slides. For lysozyme staining, sections were deparaffinized and rehydrated in descending alcohol series and quenched with 3% hydrogen peroxide in 90% ethanol for 20 min at room temperature. Sections underwent antigen retrieval by sodium citrate/citric acid solution and microwaved for 10 min, then blocked in serum-free protein blocking solution (Agilent Dako, Santa Clara, CA, USA) for 1 h at room temperature, and incubated overnight at 4 °C with rabbit anti-lysozyme antibody (1:200 dilution; product \#PA1-29680, Thermo Fisher Scientific, Waltham, MA, USA). Negative control sections were probed with normal rabbit IgG (0.4 μg/μL, 1:200; \#sc-2027, Santa Cruz Biotechnology, Dallas, TX, USA). Sections were then incubated with goat biotinylated anti-rabbit secondary antibody (1:200; \#BA-1000, Vector Labs, Burlingame, CA, USA) for 1 h at room temperature, followed by 1 h incubation with streptavidin-horseradish peroxidase (1:2000 in 1× PBS; Invitrogen, Carlsbad, CA, USA). Antibody-antigen interactions were visualized using DAB for 40 s (Vectastain DAB ABC kit, Vector Labs). Sections were counterstained with Gills I haematoxylin to provide greater contrast and to stain nuclei. Semi-quantitative analyses of ir-lysozyme staining intensity was performed using computerized image analysis (Image-Pro Plus 4.5, Media Cybernetics, Rockville, MD, USA; and Olympus BX61 microscope, Shinjuku, Tokyo, Japan). A superimage was composited from individual images (at 20× magnification) captured along the entire SI section from each dam. To semi-quantitatively measure staining intensity in each image (where higher levels of staining intensity may represent higher Lyz protein expression), an algorithm was developed (using Visiopharm NewCAST Analysis software, Hørsholm, Denmark) to detect intensity of DAB staining for ir-Lyz in four levels of intensity: low, moderate, high, and strong. Staining intensity for each of the four levels was summed across all images within a superimage for each animal. CON mothers had a mean ± SEM (range) of 10.3 ± 0.7 (7--13) images per superimage, UN had 10 ± 0.8 (7--13) images, and HF had 9 ± 0.6 (7--12) images. There was no statistical difference between diet groups in the number of images per superimage (*p* = 0.37).

For goblet cell quantification, sections were stained with alcian blue, which stains acetic mucins and acid mucosubstances. Sections were deparaffinized and rehydrated in descending alcohol series then incubated in 3% glacial acetic acid, followed by alcian blue (Sigma-Aldrich, Oakville, ON, Canada) and 0.1% nuclear fast red counterstain (Electron Microscopy Sciences, Hatfield, PA, USA). Eight images were randomly captured at 20× for each section (Leica DMIL LED inverted microscope, Wetzlar, Germany; and QCapture Pro software, Surrey, BC, Canada). We first counted the number of alcian blue positive cells (goblet cells) in one villus and one crypt nearest to the villus in each of the eight images and took the average across the images to determine the mean number of goblet cells in a villus and crypt for each animal. We also counted the number of alcian blue positive cells in two villi and two crypts nearest to these villi in each of four images (randomly selected from the eight images). The total number of epithelial cells in the same villi and crypts were also counted. The number of alcian blue positive cells and total epithelial cells across the two villi and two crypts in each image were summed. Then, the number of alcian blue positive cells and total epithelial cells were averaged across the four images (separately for villi and crypts) to obtain the average number of goblet cells and epithelial cells and the percentage of goblet cells per two villi or crypts for each animal. A researcher blinded to the experimental groups performed the counting.

2.5. Data Analysis {#sec2dot5-nutrients-11-01375}
------------------

Data were checked for normality using the Shapiro--Wilk test and equal variance using Levene's test. Outliers were excluded from analyses. Non-parametric data were transformed by applying either logarithmic, square root, or cube root transformations. Differences between dietary groups for outcome measures were analyzed using: (1) ANOVA with Tukey's post hoc, (2) Kruskal--Wallis/Wilcoxon test with Steel--Dwass post hoc for non-parametric data, or (3) Welch's test with Games--Howell post hoc for normal data with unequal variance (*p* \< 0.05) using JMP 13 software (SAS Institute, Cary, NC, USA). For qPCR and IHC data, biological replicates were CON *n* = 6--7 (*n* = 10--14 fetuses); UN *n* = 6--7 (*n* = 7--9 fetuses); and HF *n* = 7--8 (*n* = 13--15 fetuses). Data are shown as quantile box plots with 95% confidence diamonds; *p* \< 0.05.

3. Results {#sec3-nutrients-11-01375}
==========

3.1. Malnutrition Was Associated with Reduced Gut Barrier Function and Integrity {#sec3dot1-nutrients-11-01375}
--------------------------------------------------------------------------------

In UN mothers, SI mRNA expression levels of AMP genes *Lyz2* (*p* = 0.02, [Figure 1](#nutrients-11-01375-f001){ref-type="fig"}B) and *Reg3g* (*p* = 0.003, [Figure 1](#nutrients-11-01375-f001){ref-type="fig"}C) were decreased compared to CON. HF mothers had reduced mRNA expression levels of *Reg3g* (*p* = 0.003, [Figure 1](#nutrients-11-01375-f001){ref-type="fig"}C) and *Muc2* (*p* = 0.001, [Figure 1](#nutrients-11-01375-f001){ref-type="fig"}G) in SI compared to CON. There was no effect of maternal diet on the expression of AMP genes *Lyz1*, *Defa1*, *Defa5*, and *Pla2g2* ([Figure 1](#nutrients-11-01375-f001){ref-type="fig"}A,D--F). The average number of goblet cells, sites of mucus secretion, was higher in SI villi, but not crypts, of UN mothers compared CON ([Figure 2](#nutrients-11-01375-f002){ref-type="fig"}). Proportion of goblet cells relative to total number of epithelial cells in both villi and crypts were not different between dietary groups ([Figure 2](#nutrients-11-01375-f002){ref-type="fig"}).

3.2. Maternal HF Diet May Be Associated with Increased Lyz Production {#sec3dot2-nutrients-11-01375}
---------------------------------------------------------------------

Lyz protein was localized to Paneth cells in the crypts of the maternal SI ([Figure 3](#nutrients-11-01375-f003){ref-type="fig"}A). In the SI of HF dams, semi-quantitative analyses revealed a significant reduction in the levels of low-intensity Lyz staining (*p* = 0.03, [Figure 3](#nutrients-11-01375-f003){ref-type="fig"}B) compared to CON, which may suggest an overall greater production of this AMP in HF mothers. Further, an overall difference in moderate-intensity staining (*p* = 0.04; [Figure 3](#nutrients-11-01375-f003){ref-type="fig"}C) was detected, but there was no difference between groups with post hoc testing, and there were no differences between diet groups in high- or strong-intensity staining levels ([Figure 3](#nutrients-11-01375-f003){ref-type="fig"}D,E).

3.3. Maternal UN Was Associated with Delayed Fetal Gut Development and Reduced Mucus Production {#sec3dot3-nutrients-11-01375}
-----------------------------------------------------------------------------------------------

UN, but not HF, fetuses showed increased mRNA expression of the gut transcription factor *Sox9* (*p* = 0.02, [Figure 4](#nutrients-11-01375-f004){ref-type="fig"}A) compared to CON, and an associated decrease in the mRNA expression levels of *Muc2* (*p* = 0.002, [Figure 4](#nutrients-11-01375-f004){ref-type="fig"}B) and *Cdx2* (*p* = 0.003, [Figure 4](#nutrients-11-01375-f004){ref-type="fig"}C) compared to CON.

3.4. Maternal HF Diet Was Associated with Increased Fetal EGC Development {#sec3dot4-nutrients-11-01375}
-------------------------------------------------------------------------

Fetuses from HF-fed mothers had increased mRNA expression levels of EGC markers *Bfabp* (0.003, [Figure 5](#nutrients-11-01375-f005){ref-type="fig"}A) and *S100b* (*p* \< 0.001, [Figure 5](#nutrients-11-01375-f005){ref-type="fig"}B) compared to CON, and increased *Plp1* (*p* = 0.04, [Figure 5](#nutrients-11-01375-f005){ref-type="fig"}C) compared to UN. There were no differences in gut mRNA expression levels of the EGC marker *Sox10* and EGC neurotrophic factor *Gdnf* in fetuses exposed to different maternal diets ([Figure 5](#nutrients-11-01375-f005){ref-type="fig"}D,E).

3.5. Maternal HF Diet Was Associated with Increased Fetal Gut Barrier Function and Integrity {#sec3dot5-nutrients-11-01375}
--------------------------------------------------------------------------------------------

HF, but not UN, fetuses had increased mRNA expression levels of Paneth AMPs *Lyz1* (*p* = 0.007, [Figure 6](#nutrients-11-01375-f006){ref-type="fig"}A), *Reg3g* (*p* = 0.01, [Figure 6](#nutrients-11-01375-f006){ref-type="fig"}C), and *Defa1* (*p* = 0.001, [Figure 6](#nutrients-11-01375-f006){ref-type="fig"}D), and lower gut mRNA expression levels of *Tlr4* (*p* = 0.02, [Figure 6](#nutrients-11-01375-f006){ref-type="fig"}E) compared to CON. No between-group differences were detected in *Lyz2* fetal gut mRNA expression levels ([Figure 6](#nutrients-11-01375-f006){ref-type="fig"}B). Maternal HF diet was also associated with an increase in fetal gut mRNA expression of TJ genes *Cldn-3* (*p* = 0.008, [Figure 7](#nutrients-11-01375-f007){ref-type="fig"}A) and *Cldn-7* (*p* \< 0.001, [Figure 7](#nutrients-11-01375-f007){ref-type="fig"}B) compared to CON, while UN fetuses only displayed increased mRNA expression of *Cldn-7* compared to CON (*p* \< 0.001, [Figure 7](#nutrients-11-01375-f007){ref-type="fig"}B).

3.6. Maternal Malnutrition Altered Fetal Gut mRNA Expression in Males More than in Females {#sec3dot6-nutrients-11-01375}
------------------------------------------------------------------------------------------

Data on fetal outcomes were also stratified by sex ([Figure 8](#nutrients-11-01375-f008){ref-type="fig"}, [Figure 9](#nutrients-11-01375-f009){ref-type="fig"}, [Figure 10](#nutrients-11-01375-f010){ref-type="fig"} and [Figure 11](#nutrients-11-01375-f011){ref-type="fig"}). We found that maternal HF diet was associated with increased mRNA expression of genes involved in EGC maturation (*Bfabp*, *Plp1*, and *S100b*), gut barrier function (*Lyz1* and *Lyz2*), and gut barrier integrity (*Cldn-3* and *Cldn-7*) in the male fetal gut (*p* \< 0.05, [Figure 9](#nutrients-11-01375-f009){ref-type="fig"}, [Figure 10](#nutrients-11-01375-f010){ref-type="fig"} and [Figure 11](#nutrients-11-01375-f011){ref-type="fig"}) compared to CON. Maternal HF diet was also associated with reduced male fetal gut mRNA expression of the microbe-sensing toll-like receptor *Tlr4* (*p* = 0.03, [Figure 10](#nutrients-11-01375-f010){ref-type="fig"}E) compared to CON. Male UN fetuses showed a reduction in fetal gut mRNA expression of gut differentiation and maturation markers *Cdx2* (*p* = 0.02, [Figure 8](#nutrients-11-01375-f008){ref-type="fig"}B) and *Muc2* (*p* \< 0.001, [Figure 8](#nutrients-11-01375-f008){ref-type="fig"}C), and an upregulation of EGC marker *Bfabp* (*p* \< 0.001, [Figure 9](#nutrients-11-01375-f009){ref-type="fig"}A) and TJ gene *Cldn-7* (*p* = 0.004, [Figure 11](#nutrients-11-01375-f011){ref-type="fig"}B).

In female fetal guts, maternal UN was associated with increased mRNA expression of gut differentiation transcription factor *Sox9* (*p* = 0.004, [Figure 8](#nutrients-11-01375-f008){ref-type="fig"}A) compared to CON, and decreased gut maturation marker *Cdx2* (*p* = 0.02, [Figure 8](#nutrients-11-01375-f008){ref-type="fig"}B), though only compared to HF. Maternal UN was also associated with increased TJ gene *Cldn-3* (*p* = 0.03, [Figure 11](#nutrients-11-01375-f011){ref-type="fig"}A) in female fetuses compared to CON.

4. Discussion {#sec4-nutrients-11-01375}
=============

Despite the growing body of evidence linking the gut and its resident microbes to health \[[@B2-nutrients-11-01375],[@B7-nutrients-11-01375]\], few studies have investigated these relationships in the mother during pregnancy or the developing fetus. Additionally, although we know that key enteric cells that support the gut barrier and establish communication with the brain are laid down and functional in early life \[[@B49-nutrients-11-01375],[@B50-nutrients-11-01375],[@B51-nutrients-11-01375]\], we know less about how early life nutritional adversity or altered gut microbes may influence their development and function \[[@B52-nutrients-11-01375],[@B53-nutrients-11-01375]\]. Since malnutrition is an important insult to pregnancies and their outcomes \[[@B54-nutrients-11-01375]\], our study is the first to determine the effect of maternal malnutrition on maternal and fetal intestinal barrier integrity and function, and its implications for fetal development.

Extensive research has demonstrated that high fat diets markedly alter the diversity and composition of gut microbes \[[@B32-nutrients-11-01375],[@B55-nutrients-11-01375],[@B56-nutrients-11-01375],[@B57-nutrients-11-01375],[@B58-nutrients-11-01375],[@B59-nutrients-11-01375]\], resulting in long-term aberrations in gut barrier integrity \[[@B32-nutrients-11-01375],[@B55-nutrients-11-01375],[@B56-nutrients-11-01375],[@B57-nutrients-11-01375],[@B60-nutrients-11-01375]\] and function \[[@B32-nutrients-11-01375],[@B55-nutrients-11-01375],[@B61-nutrients-11-01375]\] and chronic inflammation \[[@B32-nutrients-11-01375],[@B56-nutrients-11-01375],[@B57-nutrients-11-01375]\]. As a result, we hypothesized that mothers fed a HF diet would show pronounced changes in gut function. We found that maternal HF diet was associated with reduced mRNA expression of Paneth cell AMP *Reg3g*, which targets Gram-positive bacteria \[[@B62-nutrients-11-01375]\], no change in mRNA expression of AMPs *Lyz1* and *Lyz2,* and less low-intensity Lyz staining, which may suggest an overall greater production of Lyz protein, which can target both Gram-positive and Gram-negative bacteria \[[@B63-nutrients-11-01375]\]. These results are analogous to those where HF feeding for 8 weeks in non-pregnant mice was associated with a reduction in *Reg3g* SI mRNA expression and no expression changes in *Lyz1* \[[@B61-nutrients-11-01375]\]. Maternal HF diet was also associated with lower mRNA expression levels of the goblet cell-produced *Muc2*, which when translated, becomes the main component of the mucus layer: the first line of defense against gut infections and inflammation \[[@B64-nutrients-11-01375]\]. Although this was not associated with an increase in the number of goblet cells in HF SI, our mRNA results align with a study where male and female mice fed a HF diet from weeks 6--22 of life had a reduction in mRNA expression levels of *Muc2* and cryptidins (Paneth AMPs) \[[@B65-nutrients-11-01375]\]. Since Reg3g is critical to Muc2 distribution and spatial segregation of the gut epithelium and bacteria \[[@B62-nutrients-11-01375],[@B66-nutrients-11-01375],[@B67-nutrients-11-01375]\], concurrent downregulation of these genes due to a HF diet may further alter the mucus layer and reduce gut barrier defenses against microbes, resulting in bacterial contact with the epithelium, increased gut inflammation, gut tissue damage, and bacterial translocation \[[@B62-nutrients-11-01375]\].

Similar to high fat diets, undernutrition is known to be a significant insult to gut barrier integrity and function, increasing gut permeability \[[@B68-nutrients-11-01375],[@B69-nutrients-11-01375],[@B70-nutrients-11-01375]\], gut and peripheral inflammation \[[@B68-nutrients-11-01375],[@B69-nutrients-11-01375]\], and bacterial translocation \[[@B71-nutrients-11-01375]\], and altering gut barrier structure \[[@B72-nutrients-11-01375]\] and enteric cell function \[[@B73-nutrients-11-01375],[@B74-nutrients-11-01375]\]. Despite this, and to the best of our knowledge, our study is the first to investigate the effects of undernutrition on the maternal gut barrier during pregnancy. We hypothesized that undernutrition would lead to adverse changes in the maternal gut environment. We found that moderate maternal UN was associated with lower mRNA expression levels of Paneth cell AMPs (*Lyz2* and *Reg3g*), suggesting reduced gut barrier function and ability to maintain gut-microbe homeostasis. This is consistent with findings from a study where 48 h of starvation in non-pregnant mice led to a reduction in SI mRNA and protein expression of Reg3g and Lyz, and a hyper-permeable barrier \[[@B33-nutrients-11-01375]\]. Since AMPs limit bacterial contact with the gut barrier \[[@B75-nutrients-11-01375]\], a reduction in their expression has been associated with increased bacterial adherence to the barrier \[[@B76-nutrients-11-01375]\] and bacterial translocation \[[@B1-nutrients-11-01375],[@B33-nutrients-11-01375],[@B77-nutrients-11-01375]\]. Moreover, AMPs have been shown to block the release of IL-1β from activated immune cells \[[@B78-nutrients-11-01375]\], a pro-inflammatory cytokine which exacerbates gut barrier permeability by creating gaps between TJ proteins \[[@B78-nutrients-11-01375],[@B79-nutrients-11-01375],[@B80-nutrients-11-01375]\]. These data suggest that undernutrition may compromise the host's ability to mount an appropriate immune response through AMP pathways, resulting in increased susceptibility to infections and a leaky gut. In fact, malnutrition is known to impair gut immune functioning, causing increased susceptibility to environmental insults due to altered cytokine production \[[@B81-nutrients-11-01375]\]. This may be of particular concern in pregnancies where undernutrition/underweight and infection often coexist, such as in populations with low socioeconomic status \[[@B23-nutrients-11-01375],[@B70-nutrients-11-01375]\]. Yet, even prior to bacteria reaching the gut barrier, a mucosal layer produced by goblet cells provides protection. We found that UN mothers had an increased number of villus-residing goblet cells, which may suggest an attempt to strengthen the gut barrier to offset the consequences of reduced AMP expression, such as the heightened propensity for leaky gut.

Though early life development is key to setting healthy trajectories throughout life \[[@B82-nutrients-11-01375]\], little is known about how perinatal events shape fetal gut development. Therefore, we were interested in the effect of maternal malnutrition on fetal gut and ENS development and function. We focused on the consequence of this nutritional adversity on genes involved in gut maturation and differentiation, EGC development, Paneth AMP production, and TJ formation. Consistent with our hypothesis, fetuses from HF mothers seemed to be most affected by an adverse nutritional exposure, as evidenced by significantly altered expression levels of nine of the 15 genes tested. HF diet was associated with changes in fetal EGC development, gut AMP production, and TJ expression. In fetuses from HF-fed dams, we found increased mRNA expression of specific and widely-expressed \[[@B17-nutrients-11-01375],[@B46-nutrients-11-01375],[@B83-nutrients-11-01375]\] markers of EGCs *S100b, Bfabp,* and *Plp1*, the latter of which to our knowledge has not been previously examined in the mouse fetal gut. This increase in EGC markers may be in response to the higher inflammatory environment in HF pregnancies that we have previously described \[[@B41-nutrients-11-01375]\], since EGCs are important for regulating inflammatory pathways \[[@B84-nutrients-11-01375]\] and gut barrier integrity \[[@B20-nutrients-11-01375],[@B84-nutrients-11-01375]\]. During intestinal inflammation in adult animals, EGCs respond to pro-inflammatory signals and reverse inflammation-induced ENS damage \[[@B85-nutrients-11-01375]\] by driving enteric neuron death through nitric oxide production \[[@B41-nutrients-11-01375],[@B43-nutrients-11-01375],[@B44-nutrients-11-01375]\] and triggering ENS neurogenesis \[[@B86-nutrients-11-01375]\]. Previously, EGC proliferation was shown to occur in infant rats whose mothers were fed HF diets perinatally, though mRNA and protein expression of local pro-inflammatory cytokines were unchanged at all postnatal timepoints examined (2, 4, 6, and 12 weeks) \[[@B35-nutrients-11-01375]\]. Together with our results, this may suggest that maternal HF diet exposure in utero may reprogram mechanisms in the fetus that establish gut-brain connections and communication and increase EGC development to reduce gut inflammation by the time of birth, thereby negating some of the fetal ENS damage incurred during development. Future experiments should examine whether these changes in the fetal gut are associated with altered brain development and function.

Additionally, fetuses from HF mothers showed an increase in gut mRNA expression levels of AMP genes *Lyz1* (but not *Lyz2*)*, Defa1,* and *Reg3g*. This is in contrast to studies in adult mice \[[@B27-nutrients-11-01375],[@B32-nutrients-11-01375],[@B55-nutrients-11-01375],[@B65-nutrients-11-01375]\] that have demonstrated that HF diets decrease gut levels of AMPs, though one study \[[@B29-nutrients-11-01375]\] found differing results between the mRNA and protein levels. Nevertheless, our study is the first to our knowledge to uncover how maternal malnutrition alters expression levels of AMPs in near-term fetuses and is the first to assess *Reg3g* mRNA expression in fetal tissues. Due to the lack of other developed immune mechanisms, fetuses may be increasing the expression of AMP genes to regulate and protect themselves from the pro-inflammatory fetal environment observed in HF pregnancies \[[@B87-nutrients-11-01375],[@B88-nutrients-11-01375],[@B89-nutrients-11-01375],[@B90-nutrients-11-01375]\]. In parallel to the upregulation of AMPs, we observed reduced expression of *Tlr4* mRNA in HF fetal gut, despite that, at least in adult models, *Tlr4* is known to initiate AMP production \[[@B91-nutrients-11-01375],[@B92-nutrients-11-01375]\]. Nonetheless, depending on tissue type, the same TLR can downregulate, upregulate, or not affect AMP production \[[@B93-nutrients-11-01375]\], adding to the complexity of the TLR-AMP relationship which is further compounded by the lack of work on TLR function in fetal gut tissue.

In mammals, 24 members of the claudin family exist, each with unique charge-selectivity preferences that dictate barrier permeability and tight junction structure and function \[[@B94-nutrients-11-01375]\]. Of the claudin family, *Cldn-3* and *Cldn-7* are the amongst the most highly expressed in all sections of the mouse GI tract \[[@B95-nutrients-11-01375]\]. *Cldn-3* has previously been shown to be affected by HF diets \[[@B60-nutrients-11-01375]\] and commensal bacterial colonization \[[@B96-nutrients-11-01375]\], while *Cldn-7* has been found to have functions outside of barrier integrity, such as maintenance of intestinal homeostasis \[[@B97-nutrients-11-01375]\], and both its mRNA and protein are highly expressed in the small and large intestine \[[@B97-nutrients-11-01375]\]. Still, expression levels of neither *Cldn*-3 nor *Cldn*-7 have been recorded in mouse fetal guts. In our study, fetuses from HF mothers showed an increase in mRNA expression of both TJs *Cldn-3* and *Cldn-7*, however these data run counter to the effects of HF diets on TJ expression in adult mice and rats \[[@B56-nutrients-11-01375],[@B57-nutrients-11-01375],[@B60-nutrients-11-01375]\]. Research on the ontogeny and development of tight junction proteins in the fetal mouse gut is scarce, though in human fetuses, tight junction proteins appear at 8--10 weeks of gestation and begin to assemble junctional complexes (continuous, belt-like structures around cells) at 10--12 weeks \[[@B98-nutrients-11-01375]\]. Nevertheless, most of the development of the tight junction proteins and gut integrity occurs in postnatal life \[[@B94-nutrients-11-01375]\], indicating that the prenatal fetal gut may be particularly sensitive and vulnerable to the effects of adverse in utero exposures due to a permeable gut barrier. As HF fetuses showed increased expression of TJ proteins, which is consistent with their increased expression of EGC markers, it may be that HF fetuses are compensating for a highly inflammatory maternal environment by tightening the gut barrier.

Similar to HF fetuses, we hypothesized that fetal growth restriction would lead to aberrant gut barrier development in fetuses from UN mothers. Accordingly, we found that UN fetuses had increased expression of the gut transcription factor *Sox9*, which is known to repress the expression of *Muc2* and *Cdx2* through activation of the Wnt-β-Catenin-TCF4 pathway \[[@B99-nutrients-11-01375]\], and reduced mRNA expression of mucus (*Muc2*) and gut differentiation (*Cdx2*) genes. These data are indicative of immature gut barrier development, and consistent with the reduced weight of these fetuses compared to CON and HF fetuses. Importantly, an immature gut may be associated with increased susceptibility to inflammatory and infectious insults, due to reduced gut barrier integrity and function, gut dysbiosis \[[@B100-nutrients-11-01375],[@B101-nutrients-11-01375],[@B102-nutrients-11-01375]\], and irreversible \[[@B103-nutrients-11-01375]\] aberrant nutrient absorption \[[@B103-nutrients-11-01375],[@B104-nutrients-11-01375],[@B105-nutrients-11-01375],[@B106-nutrients-11-01375]\]. This has long-term implications for growth-restricted offspring, including those born too soon, such as preterm infants, who are at greater risk for necrotizing enterocolitis \[[@B107-nutrients-11-01375],[@B108-nutrients-11-01375],[@B109-nutrients-11-01375]\] and nutrient malabsorption \[[@B103-nutrients-11-01375],[@B105-nutrients-11-01375],[@B106-nutrients-11-01375]\] due to poor gut development and function. Despite the changes in gut maturation and mucus production, fetuses from UN mothers showed an increase in gut *Cldn-7*, but not *Cldn-3*, mRNA expression, which might suggest an attempt to increase barrier integrity to compensate for the gut barrier immaturity. Lastly, our sex-stratified data suggest that the majority of observed group differences were driven by male fetuses, which is consistent with numerous reports which demonstrate that male fetuses are more susceptible to perinatal insults, especially due to maternal malnutrition \[[@B110-nutrients-11-01375],[@B111-nutrients-11-01375],[@B112-nutrients-11-01375],[@B113-nutrients-11-01375],[@B114-nutrients-11-01375],[@B115-nutrients-11-01375]\].

One limitation of our study is our focus on gene expression, especially in fetal samples where sample volume is extremely limited. Findings from qPCR data can direct future experiments that examine changes at the protein level. Another limitation is the low *n*-number in the female fetal UN group; thus, sex-stratified changes in mRNA expression should be interpreted with caution. Lastly, although our study is cross-sectional, we focused on an important developmental time (d18.5) that can serve as an indicator of embryonic/fetal experiences and provide information that could explain neonatal development and adaptations. Future studies should examine when changes in Paneth cell and EGC development and function are initiated in the pregnant mother and developing offspring, and how long they persist, which could point to critical windows for intervention to correct adverse health and developmental trajectories set by malnutrition.

5. Conclusions {#sec5-nutrients-11-01375}
==============

Our study is the first to examine the effect of both over- and undernutrition in parallel, during gestation in mice, and reveal the impact of maternal malnutrition on fetal gut Paneth cell function and EGC development---cells vital for gut barrier function and gut-brain axis connection. Our results indicate that malnutrition before and during gestation has adverse consequences for fetal gut development, maternal and fetal gut function, and potentially long-term programming of gut and brain function and gut immunity. If our findings are applicable to humans, this work may help inform research on dietary interventions that aim to prevent or mitigate the effects of being exposed to suboptimal nutrition in pregnancy (for mothers) and in early life (for offspring). Future work should place special focus on vulnerable populations wherein malnutrition and infection are more likely to coexist during pregnancy, exacerbating the negative repercussions of both noxious states on maternal and offspring wellbeing.

We deeply thank Stephen Lye for resource contributions towards the animal model; Tina Tu-Thu Ngoc Nguyen for the Lyz image capture and data collation; Ryszard Bielecki for the Lyz algorithm set up; and Enrrico Bloise for the goblet cell quantification.

The following are available online at <https://www.mdpi.com/2072-6643/11/6/1375/s1>, Figure S1: Earliest recorded expression of gut integrity, function, and development genes in the mouse fetal gut.
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![Maternal malnutrition was associated with altered gene expression of antimicrobial peptides and mucin. Maternal UN was associated with decreased mRNA expression of antimicrobial peptide genes *Lyz2* (*p* = 0.02) and *Reg3g* (*p* = 0.003) vs. CON, while HF diet was associated with decreased *Reg3g* (*p* = 0.003) and mucin (*Muc2*; *p* = 0.001) mRNA expression vs. CON (*n* = 6--8/group). Groups with different letters are significantly different (*p* \< 0.05). UN, undernourished; HF, high fat; CON, control.](nutrients-11-01375-g001){#nutrients-11-01375-f001}

![Maternal malnutrition may influence small intestinal goblet cell number. (**A**) Staining of goblet cells by alcian blue in small intestine (20× magnification). Arrows indicate goblet cells. Mean number of goblet cells across 8 villi (**B**) or crypts (**C**). Mean percentage of goblet cells (proportion of total number of epithelial cells) in villi (**D**) or crypts (**E**). There were a greater number of goblet cells in UN villi vs. CON (*p* = 0.008; *n* = 6--8/group). Groups with different letters are significantly different (*p* \< 0.05). UN, undernourished; HF, high fat; CON, control.](nutrients-11-01375-g002){#nutrients-11-01375-f002}

![Maternal HF diet was associated with less low-intensity lysozyme staining in intestinal crypts. (**A**) Representative images of lysozyme protein immunoreactivity (ir) staining show localization to the crypts of the maternal small intestine (SI) at d18.5, with negative control inset (40× magnification). Arrows indicate lysozyme proteins within Paneth cells. (**B**--**E**) Lyz staining was quantified into low, moderate, high, and strong intensities, representing increasing levels of protein expression (*n* = 6--8/group). Semi-quantitative analysis revealed less low-intensity Lyz staining in SI from HF mothers (*p* = 0.03) vs. CON, and an overall difference in moderate-intensity Lyz staining (*p* = 0.04), but no difference between groups with post hoc testing. Groups with different letters are significantly different (*p* \< 0.05). UN, undernourished; HF, high fat; CON, control.](nutrients-11-01375-g003){#nutrients-11-01375-f003}

![UN fetuses displayed activation of a gut transcription factor that represses gut barrier development and mucus production. Maternal UN was associated with increased fetal gut mRNA expression of *Sox9* (*p* = 0.02) vs. CON, and decreased *Muc2* (*p* = 0.002) and *Cdx2* (*p* = 0.003) vs. CON (*n* = 8--15/group). Groups with different letters are significantly different (*p* \< 0.05). UN, undernourished; HF, high fat; CON, control.](nutrients-11-01375-g004){#nutrients-11-01375-f004}

![HF fetuses showed activation of enteric glial cell markers in the gut. Maternal HF diet was associated with increased fetal gut mRNA expression of enteric glial cells (EGC) markers *S100b* (*p* \< 0.001) and *Bfabp* (*p* = 0.003) vs. CON, and *Plp1* (*p* = 0.04) vs. UN (*n* = 7--15/group). Groups with different letters are significantly different (*p* \< 0.05). UN, undernourished; HF, high fat; CON, control.](nutrients-11-01375-g005){#nutrients-11-01375-f005}

![HF fetuses showed an upregulation of gut barrier function genes and downregulation of a microbe-sensing receptor. Maternal HF diet was associated with increased mRNA expression of antimicrobial peptide (AMP) genes *Lyz1* (*p* = 0.007), *Reg3g* (*p* = 0.01), and *Defa1* (*p* = 0.001) in the fetal gut vs. CON, though mRNA expression of the purported AMP-activating receptor *Tlr4* was decreased in these fetuses (*p* = 0.02) vs. CON (*n* = 9--15/group). Groups with different letters are significantly different (*p* \< 0.05). UN, undernourished; HF, high fat; CON, control.](nutrients-11-01375-g006){#nutrients-11-01375-f006}

![Maternal malnutrition altered fetal gut tight junction gene expression. Maternal UN was associated with increased mRNA expression of *Cldn-7* (*p* \< 0.001) in fetal gut vs. CON, while fetuses from HF mothers increased *Cldn-3* (*p* = 0.008) and *Cldn-7* (*p* \< 0.001) mRNA expression vs. CON (*n* = 9--15/group). Groups with different letters are significantly different (*p* \< 0.05). UN, undernourished; HF, high fat; CON, control.](nutrients-11-01375-g007){#nutrients-11-01375-f007}

![Maternal UN affected fetal gut barrier maturity in both sexes and mucus layer maturity in male fetuses only. Maternal UN was associated with increased gut transcription factor *Sox9* (*p* = 0.004) vs. CON and decreased *Cdx2* (*p* = 0.02) vs. HF in female fetal guts, and reduced *Cdx2* (*p* = 0.02) and *Muc2* (*p* \< 0.001) vs. CON in male fetal guts (*n* = 3--8/group). Groups with different letters are significantly different (*p* \< 0.05). UN, undernourished; HF, high fat; CON, control.](nutrients-11-01375-g008){#nutrients-11-01375-f008}

![Maternal HF diet was associated with increased mRNA expression of enteric glial cell markers in male fetuses. In male fetal guts, maternal HF diet was associated with increased *Bfabp* (*p* \< 0.001), *S100b* (*p* \< 0.001), and *Plp1* (*p* = 0.001), while maternal UN was associated with increased *Bfabp* (*p* \< 0.001). Maternal malnutrition (UN and HF) did not affect enteric glial cell development in female fetal guts (*n* = 3--8/group). Groups with different letters are significantly different (*p* \< 0.05). UN, undernourished; HF, high fat; CON, control.](nutrients-11-01375-g009){#nutrients-11-01375-f009}

![Maternal HF diet was associated with increased expression of antimicrobial peptides and decreased expression of microbe-sensing receptor in male fetuses. In male fetal guts, maternal HF diet was associated with increased *Lyz1* (*p* \< 0.001) and *Lyz2* (*p* \< 0.001), and decreased *Tlr4* (*p* = 0.03) mRNA expression levels. Maternal malnutrition (UN and HF) did not affect *Defa1* or *Reg3g* expression levels in male fetuses or antimicrobial peptide levels in female fetal guts (*n* = 3--8/group). Groups with different letters are significantly different (*p* \< 0.05). UN, undernourished; HF, high fat; CON, control.](nutrients-11-01375-g010){#nutrients-11-01375-f010}

![Maternal malnutrition was associated with an increase in gut tight junction gene expression in both fetal sexes. In male fetal guts, maternal HF diet was associated with increased *Cldn-3* (*p* = 0.02) and *Cldn-7* (*p* = 0.004), while maternal UN was associated with increased *Cldn-7* (*p* = 0.004); in female fetal guts, maternal UN was associated with increased *Cldn-3* (*p* = 0.03) mRNA expression (*n* = 3--8/group). Groups with different letters are significantly different (*p* \< 0.05). UN, undernourished; HF, high fat; CON, control.](nutrients-11-01375-g011){#nutrients-11-01375-f011}
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###### 

Primer sequences for quantitative PCR.

  Gene                                  Sequence 5'--3'                     Source
  ------------------------------------- ----------------------------------- ---------------------------
  Gut barrier function markers                                              
  *Lyz1*                                **F**-GGGAACCTGTGACCTGTCTT          Accession: NM_013590.4
  **R**-GCCTCATGACACTGGGAACA                                                
  *Lyz2*                                **F**-TCTACTGCAGCTCATTCGGT          Accession: NM_017372.3
  **R**-CTTAGAGGGGAAATCGAGGGAA                                              
  *Pla2g2*                              **F**-AGGATTCCCCCAAGGATGCCAC        PMID: 19855381
  **R**-CAGCCGTTTCTGACAGGAGTTCTGG                                           
  *Defa1*                               **F**-TCAAGAGGCTGCAAAGGAAGAGAAC     PMID: 19855381
  **R**-TGGTCTCCATGTTCAGCGACAGC                                             
  *Defa5*                               **F**-CTTGTCCTGCTGGCCTTCC           Accession: NM_007851.2
  **R**-TAGACACAGCCTGGTCCTCT                                                
  *Reg3g*                               **F**-CCATCTTCACGTAGCAGC            PMID: 22723890
  **R**-CAAGATGTCCTGAGGGC                                                   
  *Tlr4*                                Bio-Rad (Mississauga, ON, Canada)   Assay ID: qMmuCID0023548
  Gut barrier integrity markers                                             
  *Muc2*                                **F**-ACCTGGAAGGCCCAATCAAG          Accession: NM_023566.3
  **R**-CAGCGTAGTTGGCACTCTCA                                                
  *Cldn-3*                              **F**-GCACCCACCAAGATCCTCTA          PMID: 17383680
  **R**-AGGCTGTCTGTCCTCTTCCA                                                
  *Cldn-7*                              **F**-CATTGTGGCAGGTCTTGCTG          Accession: NM_016887.6
  **R**-CATGGGCGTCAAGGGGTTAT                                                
  EGC maturation and function markers                                       
  *Bfabp*                               **F**-GGTTCGGTTGGATGGAGACA          Accession: NM_021272.3
  **R**-AGTCACGACCATCTTGCCAT                                                
  *S100b*                               **F**-TGGCTGCGGAAGTTGAGATT          Accession: NM_009115.3
  **R**-ATGGCTCCCAGCAGCTAAAG                                                
  *Gdnf*                                **F**-ACCAGTGACTCCAATATGCCTG        Accession: NM_001301357.1
  **R**-CTGCCGCTTGTTTATCTGGTG                                               
  *Sox10*                               Bio-Rad (Mississauga, ON, Canada)   Assay ID: qMmuCID0007045
  *Plp1*                                Bio-Rad (Mississauga, ON, Canada)   Assay ID: qMmuCED0061105
  Fetal gut development markers                                             
  *Cdx2*                                **F**-AGCCAAGTGAAAACCAGGAC          Accession: NM_007673.3
  **R**-AGTGAAACTCCTTCTCCAGCTC                                              
  *Sox9*                                **F**-GCCACGGAACAGACTCACAT          Accession: NM_011448.4
  **R**-AGATTGCCCAGAGTGCTCG                                                 
  Reference genes                                                           
  *Ywhaz*                               **F**-GCAACGATGTACTGTCTCTTTTGG      Accession: NM_011740.3
  **R**-GTCCACAATTCCTTTCTTGTCATC                                            
  *Tbp*                                 **F**-CGGACAACTGCGTTGATTTTC         Accession: NM_013684.3
  **R**-AGCCCAACTTCTGCACAACTC                                               
  *Actb*                                **F**-TCGTGCGTGACATCAAAGAGA         Accession: NM_007393.5
  **R**-GAACCGCTCGTTGCCAATA                                                 

*Lyz*, Lysozyme; *Pla2g2*, Phospholipase A2 Group II; *Defa*, Alpha Defensin; *Reg3g*, Regenerating Family Member 3 Gamma; *Tlr4*, Toll-Like Receptor 4; *Muc2*, Mucin 2; *Cldn*, Claudin; *Bfabp*, Brain-Type Fatty Acid-Binding Protein; *S100b*, S100 Calcium Binding Protein B; *Gdnf*, Glial-Derived Neurotrophic Factor; *Sox10*, SRY-Box 10; *Plp1*, Proteolipid Protein 1; *Cdx2*, Caudal Type Homeobox 2; *Sox9*, SRY-Box 9; *Ywhaz*, Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Zeta; *Tbp*, TATA-Box Binding Protein; *Actb*, Beta-actin; F, Forward primer; R, Reverse primer; PMID, PubMed Identification.
